Kiromic Biopharma, Inc. Total Liabilities
Kiromic Biopharma, Inc. had Total Liabilities of $21.13 million as of 2024-12-31, per its 10-K filed 2025-02-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2025-02-14
- 2024-12-31: Liabilities $21.13M.
- 2024-09-30: Liabilities $19.53M.
- 2024-06-30: Liabilities $17.63M.
- 2024-03-31: Liabilities $19.84M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2024-12-31 | $21.13M 10-K · filed 2025-02-14 | |
| 2024-09-30 | $19.53M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $17.63M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $19.84M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $21.29M 10-K · filed 2025-02-14 | $21.29M 10-K · filed 2024-03-19 |
| 2023-09-30 | $18.72M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $19.93M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $21.25M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $17.74M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $12.74M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $7.74M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $5.86M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $3.41M 10-K · filed 2023-04-17 | |
| 2021-09-30 | $1.44M 10-Q · filed 2022-03-11 | |
| 2021-06-30 | $1.57M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $1.70M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $1.47M 10-K · filed 2022-04-08 | |
| 2020-09-30 | $2.25M 10-Q · filed 2020-11-30 | |
| 2019-12-31 | $673.70K 10-K · filed 2021-03-31 |